REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
20/10/2025
Voltar para busca
Dado oficial do USPTO
OSLER DELPHI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
OSLER DELPHI
ST13
US500000079253505Classe
1, 5, 9, 10, 41, 42, 44, 45
Pedido
79253505
Registro
6177054
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
22/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 41, 42, 44, 45
Data de depósito
29/01/2019
Data de registro
20/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/10/2020
Última transação
22/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Oxford, GB
Examinador
LEE, DOUGLAS
Unidade examinadora
M40
Localização atual
TMO LAW OFFICE 113
Titulares e representantes
Titulares
Osler Diagnostics Limited
Osler Diagnostics Limited
Representantes
Eric Lamb Frost Brown Todd LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 41Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Assays and reagents for scientific or medical research purposes
Classe 5
Pharmaceuticals for treating virusesinfectionsinfectious diseasesskin disorders; medical preparations for treating virusesinfectionsinfectious diseasesskin disorders; chemical preparations and reagents for medical purposes for treating virusesinfectionsinfectious diseasesskin disorders; diagnostic preparationssubstancesagentsreagentsassays and materials for medical purposes; diagnostic testing preparationssubstancesagentsreagentsassays and materials for medical purposesfor testing blood and body fluids
Classe 9
Scientific apparatus and instrumentshand-held devices for withdrawing and testing blood for clinicalresearchscientific purposes and parts and fittings therefor; material testing apparatus and instrumentselectronic apparatus for identifying and testing pathogens and biomarkers in blood for clinicalresearchscientific purposes; monitoringmeasuringsignaling and control apparatus and instrumentsapparatus and instruments for testing blood against a panel of biomarkers for clinicalresearchscientific purposes; audiovisual receivers; computer apparatus and instrumentscomputer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; recorded application software for analyzing data obtained from blood samples; computer hardware for data capturecollectionrecordingprocessingtransmissionreproductionstorage and communications; electrical and electronic components for computers; parts and fittings for all the aforementioned goods *none of the aforementioned services being related toconnected with or for use in or relating to vehiclesincluding but not limited to automotiveaircraftwatercraftvehicle partsvehicle accessoriesvehicle component systems or the automotive industrybeing related to or connected with the fields of transportation and mobility *
Classe 10
Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for testing blood for diagnostic use; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goods
Classe 41
Research in the field of education; consultancyadvisory and/or information services relating to or connected with the aforementioned services *none of the aforementioned services being related toconnected with or for use in or relating to vehiclesincluding but not limited to automotiveaircraftwatercraftvehicle partsvehicle accessoriesvehicle component systems or the automotive industrybeing related to or connected with the fields of transportation and mobility *
Classe 42
Product research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; researchdesign and development of medical apparatus and instruments; researchdesign and development of medical diagnostic apparatus and instruments; researchdesign and development of diagnostic tests for the measurement of clinical biomarkers; consultancyadvisory and/or information services relating to or connected with the aforementioned services *none of the aforementioned services being related toconnected with or for use in or relating to vehiclesincluding but not limited to automotiveaircraftwatercraftvehicle partsvehicle accessoriesvehicle component systems or the automotive industrybeing related to or connected with the fields of transportation and mobility *
Classe 44
Medical services; medical testing for diagnostic purposes; medical testingscreening and analysis services relating to the diagnosis and/or treatment of disease; consultancyadvisory and/or information services relating to or connected with the aforementioned services
Classe 45
Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents and intellectual property in the field of confidential informationtechnical information and/or know-how; consultancyadvisory and/or information services relating to or connected with the aforementioned services
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/09/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/07/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/06/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
11/05/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/02/2023
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
08/11/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/10/2022
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
04/10/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/09/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
05/06/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
25/04/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/02/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/02/2021
FIMP
FINAL DISPOSITION PROCESSED
02/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
20/10/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
10/09/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/08/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/08/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/08/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
30/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
28/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
22/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
22/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/07/2019
RFNT
REFUSAL PROCESSED BY IB
12/07/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/07/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/06/2019
RFRR
REFUSAL PROCESSED BY MPU
24/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/06/2019
CNRT
NON-FINAL ACTION WRITTEN
10/06/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
07/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/05/2019
CNRT
NON-FINAL ACTION WRITTEN
18/05/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
03/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/04/2019
CNRT
NON-FINAL ACTION WRITTEN
17/04/2019
DOCK
ASSIGNED TO EXAMINER
10/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
15/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OSLER DELPHI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.